Post-tuberculosis lung disease: clinical review of an under-recognised global challenge
An estimated 58 million people have survived tuberculosis since 2000, yet many of them will
suffer from post-tuberculosis lung disease (PTLD). PTLD results from a complex interplay …
suffer from post-tuberculosis lung disease (PTLD). PTLD results from a complex interplay …
Inhaled corticosteroids in COPD: friend or foe?
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …
[HTML][HTML] Tuberculosis and chronic respiratory disease: a systematic review
Background Chronic respiratory disease causes substantial global morbidity and mortality.
The contribution of pulmonary tuberculosis to the aetiology of chronic respiratory disease is …
The contribution of pulmonary tuberculosis to the aetiology of chronic respiratory disease is …
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
M Miravitlles, A Auladell-Rispau… - European …, 2021 - Eur Respiratory Soc
Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …
however, a significant proportion of patients at low risk of exacerbations are treated with …
[HTML][HTML] Corticosteroids for COVID-19 therapy: potential implications on tuberculosis
R Gopalaswamy, S Subbian - International journal of molecular sciences, 2021 - mdpi.com
On 11 March 2020, the World Health Organization announced the Corona Virus Disease-
2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID …
2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID …
[HTML][HTML] Pathophysiological mechanisms of asthma
A Bush - Frontiers in pediatrics, 2019 - frontiersin.org
The recent Lancet commission has highlighted that “asthma” should be used to describe a
clinical syndrome of wheeze, breathlessness, chest tightness, and sometimes cough. The …
clinical syndrome of wheeze, breathlessness, chest tightness, and sometimes cough. The …
Inhaled corticosteroids safety and adverse effects in patients with asthma
E Heffler, LNG Madeira, M Ferrando, F Puggioni… - The Journal of Allergy …, 2018 - Elsevier
Asthma is a common inflammatory airway disease for which the most commonly used
controller medications are inhaled corticosteroids (ICS). Asthma control is difficult to achieve …
controller medications are inhaled corticosteroids (ICS). Asthma control is difficult to achieve …
The risk of mycobacterial infections associated with inhaled corticosteroid use
Inhaled corticosteroid (ICS) use is associated with an increased risk of pneumonia. This
study was performed to determine if ICS use is associated with an increased risk of …
study was performed to determine if ICS use is associated with an increased risk of …
Inhaled corticosteroids in COPD: the clinical evidence
In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
While the pharmacological management of chronic obstructive pulmonary disease (COPD)
has evolved from the drugs used to treat asthma, the treatment models are different and the …
has evolved from the drugs used to treat asthma, the treatment models are different and the …